Clinical value of whole-body positron emission tomography in potentially curable colorectal liver metastases

European Journal of Surgical Oncology

Volumn 27, Issue 2, 2001, Pages 175-179

  Topal, B ^a   Flamen, P ^a   Aerts, R ^a   D'Hoore A ^a   Filez, L ^a   Van Cutsem, E ^a   Mortelmans, L ^a   Penninckx, F ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Colorectal cancer; Liver; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INFORMATION; INTRAOPERATIVE PERIOD; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TIME; WHOLE BODY SCINTISCANNING;

EID: 0034943862     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.1075     Document Type: Article

References (26)

1. Resection of liver tumors: Special emphasis on neoadjuvant and adjuvant therapy
2. Liver metastases from colorectal cancer: Lessons from past and present clinical studies
3. FDG accumulation and tumor biology
4. 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases
5. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer
6. Nonparametric estimation from incomplete observations
7. The approach to the patient with single and multiple liver metastases, pulmonary metastases, and intra-abdominal metastases from colorectal carcinoma
8. Patient selection and treatment of peritoneal carcinomatomas from colorectal and appendicel cancer
9. Intra-abdominal extrahepatic disease in patients with colorectal hepatic metastases
10. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results
11. Follow-up plans after treatment of primary colon and rectum cancer
12. Routine compared with nonscheduled follow-up of patients with 'curative' surgery for colorectal cancer
13. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer
14. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer
15. Recurrent rectal cancer and scar: Differentiation with PET and MR imaging
16. Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging
17. Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography
18. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings
19. 18F)fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver
20. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
21. 18F) fluorodeoxyglucose in recurrent colorectal cancer
22. Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms
23. Cost-effectiveness of PET imaging in clinical oncology
24. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumor response to fluorouracil